Literature DB >> 25573986

A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow.

Henrik E Mei1, Ina Wirries1, Daniela Frölich1, Mikael Brisslert2, Claudia Giesecke1, Joachim R Grün3, Tobias Alexander4, Stefanie Schmidt1, Katarzyna Luda1, Anja A Kühl5, Robby Engelmann6, Michael Dürr7, Tobias Scheel8, Maria Bokarewa2, Carsten Perka9, Andreas Radbruch10, Thomas Dörner1.   

Abstract

Specific serum antibodies mediating humoral immunity and autoimmunity are provided by mature plasma cells (PC) residing in the bone marrow (BM), yet their dynamics and composition are largely unclear. We here characterize distinct subsets of human PC differing by CD19 expression. Unlike CD19(+) PC, CD19(-) PC were restricted to BM, expressed predominantly IgG, and they carried a prosurvival, distinctly mature phenotype, that is, HLA-DR(low)Ki-67(-)CD95(low)CD28(+)CD56(+/-), with increased BCL2 and they resisted their mobilization from the BM after systemic vaccination. Fewer mutations within immunoglobulin VH rearrangements of CD19(-) BMPC may indicate their differentiation in early life. Their resistance to in vivo B-cell depletion, that is, their independency from supply with new plasmablasts, is consistent with long-term stability of this PC subset in the BM. Moreover, CD19(-) PC were detectable in chronically inflamed tissues and secreted autoantibodies. We propose a multilayer model of PC memory in which CD19(+) and CD19(-) PC represent dynamic and static components, respectively, permitting both adaptation and stability of humoral immune protection.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25573986     DOI: 10.1182/blood-2014-02-555169

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  67 in total

1.  Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy.

Authors:  Vijay G Bhoj; Dimitrios Arhontoulis; Gerald Wertheim; James Capobianchi; Colleen A Callahan; Christoph T Ellebrecht; Amrom E Obstfeld; Simon F Lacey; Jan J Melenhorst; Farzana Nazimuddin; Wei-Ting Hwang; Shannon L Maude; Mariusz A Wasik; Adam Bagg; Stephen Schuster; Michael D Feldman; David L Porter; Stephen A Grupp; Carl H June; Michael C Milone
Journal:  Blood       Date:  2016-05-10       Impact factor: 22.113

Review 2.  Serology in the 21st century: the molecular-level analysis of the serum antibody repertoire.

Authors:  Yariv Wine; Andrew P Horton; Gregory C Ippolito; George Georgiou
Journal:  Curr Opin Immunol       Date:  2015-07-10       Impact factor: 7.486

3.  CD19-positive antibody-secreting cells provide immune memory.

Authors:  C J Groves; J Carrell; R Grady; B Rajan; C A Morehouse; R Halpin; J Wang; J Wu; Y Shrestha; R Rayanki; R Kolbeck; Y Wang; R Herbst
Journal:  Blood Adv       Date:  2018-11-27

Review 4.  Treatment of membranous nephropathy: time for a paradigm shift.

Authors:  Piero Ruggenenti; Fernando C Fervenza; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

Review 5.  Plasma cells as an innovative target in autoimmune disease with renal manifestations.

Authors:  Falk Hiepe; Andreas Radbruch
Journal:  Nat Rev Nephrol       Date:  2016-02-29       Impact factor: 28.314

Review 6.  [Therapy-resistant cells of the B cell line].

Authors:  B F Hoyer; T Dörner
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

Review 7.  Metabolic Links between Plasma Cell Survival, Secretion, and Stress.

Authors:  Wing Y Lam; Deepta Bhattacharya
Journal:  Trends Immunol       Date:  2017-09-11       Impact factor: 16.687

8.  Stable HLA antibodies following sustained CD19+ cell depletion implicate a long-lived plasma cell source.

Authors:  Zheng Zhang; Stephen J Schuster; Simon F Lacey; Michael C Milone; Dimitri Monos; Vijay G Bhoj
Journal:  Blood Adv       Date:  2020-09-22

Review 9.  Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.

Authors:  Nicole Baumgarth; Janko Nikolich-Žugich; F Eun-Hyung Lee; Deepta Bhattacharya
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

10.  To B or not to B maintained?

Authors:  Anna-Karin E Palm; Patrick C Wilson
Journal:  Blood       Date:  2016-07-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.